•  

Posts Tagged: Maple Leaf Angels

MLA48 Angel Investment Fund Completes Third Investment in UTEST Company

MLA48 leads ConferenceCloud pre-seed round in cooperation with UTEST TORONTO, CANADA (January 11, 2016) — MLA48, Canada’s first angel investment fund committed to providing a 48-hour turnaround on investment decisions, has announced its third investment in ConferenceCloud, an innovative digital platform that provides a virtual solution for the next generation of hybrid conference events. TechVibes and BetaKit covered this announcement. The University of Toronto also published a web story on Olivia and John-Alan Simmons and their start-up journey. Founded in 2014 by siblings Olivia ...
January 11, 2016 in ConferenceCloud, Funding or Fundraising-Announcements, Media Coverage, Member Institutions, News, Portfolio, Start-Up Companies, University of Toronto
Read more

ChipCare closes oversubscribed $5 million series A financing

With lead investment from Puffin Partners, the Ontario, Canada-based company is taking lifesaving blood-testing technology to low- and middle-income countries TORONTO, March 3, 2015 — ChipCare Corporation, a University of Toronto start-up company commercializing a handheld, blood-testing platform for HIV and other infectious and non-communicable diseases has closed a $5.045 million Series A financing to bring its first-generation product to market while further developing the platform’s next generation products. The Wall Street Journal's Venture Capital Dispatch blog, Yonge Street Media, BetaKit and PEHub ...
March 3, 2015 in ChipCare Corporation, Funding or Fundraising-Announcements, Government Partners, Media Coverage, Member Institutions, News, Partnerships, Portfolio, Start-Up Companies, University of Toronto
Read more

ChipCare’s handheld analyzer attracts one of Canada’s largest-ever healthcare angel investments

Device could significantly improve HIV diagnostics in developing world OTTAWA, September 16, 2013 — An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of $2.05M to support ChipCare's continuing development and commercialization over the next three years. Media coverage: Biotechnology Focus, TechVibes, BetaKit, Healthrender, Crunchbase, Toronto Star and VentureLab. The financing evolved through a uniquely collaborative funding model among Canadian social angel investors, including ...
September 16, 2013 in ChipCare Corporation, Funding or Fundraising-Announcements, International Projects, Member Institutions, News, Partnerships, Portfolio, Start-Up Companies, University of Toronto
Read more